![Jeffrey G. Hesselberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey G. Hesselberg
Algemeen Adviseur bij
Castle Creek Biosciences, Inc.
Profiel
Jeffrey G.
Hesselberg is currently the Vice President-Regulatory & Quality Affairs at Castle Creek Biosciences, Inc. He previously worked as the Director-Regulatory Affairs at ICOS Corp.
from 1996 to 2007 and as the Vice President-Regulatory Affairs at GTx, Inc. He holds an MBA degree from the University of Washington and an undergraduate degree from the University of Wisconsin.
Actieve functies van Jeffrey G. Hesselberg
| Bedrijven | Functie | Begin |
|---|---|---|
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Algemeen Adviseur | 01-01-2020 |
Eerdere bekende functies van Jeffrey G. Hesselberg
| Bedrijven | Functie | Einde |
|---|---|---|
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Algemeen Adviseur | 01-04-2007 |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Algemeen Adviseur | - |
Opleiding van Jeffrey G. Hesselberg
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
